Wize Pharma (acquired by Ophthalix)'s P2P Acquisition

Wize Pharma (acquired by Ophthalix) raised a round of funding on November 16, 2017. Investors include Wize Pharma.

Wize Pharma is a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders.…

Articles about Wize Pharma (acquired by Ophthalix)'s P2P Acquisition: